Posts

Showing posts with the label Healthcare Spending Statistics

Glucosamine

Image
Glucosamine is a supplement derived from shellfish. Glucosamine is primarily sold as a joint health supplement. Studies show that supplementing glucosamine sulfate will reduce the rate of collagen (joint tissue) degradation and symptoms of osteoarthritis. Though glucosamine is comparable to acetaminophen, the reference drug for osteoarthritis, in potency, it is not as reliable. Studies on athletes supplementing glucosamine are limited, but preliminary evidence suggests doses as high as 3,000mg of glucosamine sulfate may be able to slow joint degradation. This effect is most relevant for athletes participating in high impact sports, like running. Though preliminary evidence suggested glucosamine supplementation could cause insulin resistance, follow up studies conclude that glucosamine supplementation does not affect glucose metabolism. Glucosamine is very safe to supplement and its most common side-effect is flatulence. Glucosamine supplementation cannot cure osteoarthritis, but

Healthcare Spending Statistics

Image
The aim of this article is to present the relevant statistics on the United States' healthcare regarding financing and expenditure. These statistics are useful in the evaluation of a country's healthcare with regards to global access to quality healthcare.The statistics analyze the financial resources and the allocation process of such resources between the various beneficiaries and stakeholders in the broad health sector, for instance, healthcare providers such as hospitals and health care that is either preventive or curative. National healthcare spending statistics In the US, approximately 50% of medical costs are for hospital expenses, the breakdown being, hospital inpatient-30% and outpatient-19%. Prescription medication gets 17% while doctors get 30%. In the above distribution, the amount allocated for drugs is small as compared to the overall expenditure, and as a result, there have been growing concerns over the rising cost of new medication, and this can gi